Healthcare is one of the biggest areas of opportunity for AI, with more than 500 health AI algorithms cleared by the FDA over the last several years.

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

When used to flag anomalies in combined chest and musculoskeletal X-rays, imaging AI can relieve overstretched emergency radiology teams.

The FDA has OK’d a new artificial intelligence platform for quickly diagnosing stroke on unenhanced CT scans.

One of the 10 largest banks in the country is marketing a new AI-based system aimed at flagging upcoming medical claims that are likely to court rejection by payers.

Using CT scans, a deep learning algorithm can recommend optimal lung cancer screening intervals by distinguishing between high-risk and low-risk lung nodules. 

The first quantum computer set up to support healthcare research in the United States has been delivered.

The 211-year-old New England Journal of Medicine has birthed an online-only monthly journal that will take on “some of the most pressing questions in medicine through the application of AI in the clinic.”